|
WO2020190703A1
|
|
Methods for wound treatment
|
|
WO2020102326A1
|
|
Methods for determining and increasing nad levels
|
|
WO2019209840A1
|
|
Methods and compositions for treating rheumatoid arthritis
|
|
WO2019126482A1
|
|
Crystalline forms of nicotinamide riboside chloride
|
|
WO2019108873A1
|
|
Methods and compositions for treating multiple sclerosis
|
|
WO2019108878A1
|
|
Methods and compositions for treating childhood or teen obesity
|
|
US2020384004A1
|
|
Methods and compositions for treating glaucoma
|
|
WO2019089417A1
|
|
Methods and compositions for treating cystic fibrosis
|
|
WO2019079686A1
|
|
Prevention and treatment of tdp-43 associated diseases
|
|
EP3691622A1
|
|
Methods and compositions for treating premature aging diseases
|
|
WO2019006262A1
|
|
Methods of synthesizing nicotinamide riboside
|
|
WO2018213715A1
|
|
Methods and compositions for improving sleep
|
|
AU2018260616A1
|
|
Treating and preventing kidney damage
|
|
WO2018200357A1
|
|
Methods and compositions of improving fertility
|
|
CN110769834A
|
|
Nicotinamide nucleosides for treating or preventing liver injury
|
|
CN109982706A
|
|
For treating the nicotinamide riboside of Neurodegenerative conditions and the composition and method of pterostilbene
|
|
AU2016274126A1
|
|
Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
|
